Earnings Data
Report Date
Nov 12, 2026TBA (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.47Last Year’s EPS
-0.51Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
DE:69C Q2 2026 Earnings Report
DE:69C Upcoming Earnings
Tvardi Therapeutics's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
DE:69C Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:69C Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 14, 2026 | €0.94 | €0.94 | 0.00% |
May 08, 2026 | €2.52 | €2.98 | +18.25% |
Mar 31, 2026 | €2.21 | €2.15 | -2.71% |
Nov 13, 2025 | €2.99 | €2.92 | -2.17% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Tvardi Therapeutics (DE:69C) report earnings?
Tvardi Therapeutics (DE:69C) is schdueled to report earning on Nov 12, 2026, TBA (Confirmed).
What is Tvardi Therapeutics (DE:69C) earnings time?
Tvardi Therapeutics (DE:69C) earnings time is at Nov 12, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Tvardi Therapeutics stock?
The P/E ratio of Tvardi Therapeutics is N/A.
What is DE:69C EPS forecast?
DE:69C EPS forecast for the fiscal quarter 2026 (Q3) is -0.47.